Manipal Natural: Transforming India's Botanical Wealth Into Globally Trusted Ingredients

Syed Saleel, Executive Director

Syed Saleel

Executive Director

The botanical extracts industry is undergoing a funda­mental shift. As pharmaceutical, nutraceutical, food and wellness companies increasingly turn to plant-derived ingredients, the emphasis is moving beyond natural origins toward scientific validation, purity, traceability and consistent performance. For manufacturers, the challenge is to transform inherently variable agricultural materials into standardized ingredients capable of meeting stringent international specifi­cations.

Positioned at this intersection is Manipal Natural Pvt. Ltd., a botanical extracts manufacturer combining India's rich botanical resources with advanced extraction processes, ana­lytical capabilities and responsible sourcing practices. Backed by the century-long legacy of the Manipal Group, the compa­ny is strengthening its position as a dependable supplier of high-purity, standardized botanical ingredients for domestic and international markets.

From Botanical Commodities to Science- Backed Ingredients

Manipal Natural's proposition reflects a significant change in customer expectations. Buyers increasingly seek ingredients that are not only naturally sourced but also demonstrate predictable potency, documented purity and suitability for specific applications. The company's portfolio includes standardized extracts derived from Coleus Forskohlii, Turmeric, Ashwagandha, Gymnema, Boswellia, Bacopa, Garcinia, Salacia, Shatavari and other extracts. These ingredients serve evolving requirements across metabolic health, cognitive wellness, joint health and preventive nutrition.

Rather than competing primarily on commodity pricing, Manipal Natural is focusing on differentiated formulations, customized specifications and technical documentation. Its development priorities include water-soluble Curcumin, Coleus Forskohlii, Salacia and enhanced-bioavailability of botanical ingredients, alongside application-oriented solutions for functional foods and beverages.

"Our vision is to build a globally respected botanical ingredients enterprise that integrates India's rich botanical heritage with advanced extraction technologies and rigorous quality standards," shares Syed Saleel. This approach positions the company as a botanical solutions partner capable of addressing both formulation requirements and international quality expectations.

Building Consistency from Farm to Finished Extract

One of the industry's greatest challenges is producing consistent extracts from agricultural inputs whose phytochemical composition varies with geography, climate and harvesting conditions. Manipal Natural addresses this variability before extraction begins. Its sourcing network extends across Tamil Nadu, Karnataka, Madhya Pradesh, Uttar Pradesh, Rajasthan and Chhattisgarh, supported by farmer relationships and approximately 10–12 established aggregators.

Incoming raw materials undergo checks for active content, moisture and foreign matter. Validated standard operating procedures govern solvent ratios, extraction temperatures, processing durations and drying parameters, reducing variations between production batches. Analytical controls extend across raw materials, intermediate stages and finished extracts. In-house HPLC, GC and UV testing are supplemented by NABL-accredited external laboratories for contaminants, including pesticide residues, heavy metals and aflatoxins.

Customers receive comprehensive documentation covering analytical results, traceability, stability and process information, strengthening confidence in ingredient quality. "In a business where nature is inconsistent, the only thing that must be absolutely consistent is our integrity," says Madhukumar. His operational philosophy emphasizes validated processes over shortcuts, supported by disciplined quality management and transparent customer audits.

Leadership, Accountability and Operational Excellence

As Manipal Natural scales, its leadership recognizes that manufacturing infrastructure alone cannot guarantee sustainable growth. Equally important are capable teams, clearly defined responsibilities and systems that function independently of individual intervention.

The company's leadership strategy brings together the complementary expertise of Syed Saleel, Vivek Tapuriah and Madhukumar, ensuring that commercial growth, innovation, talent development and operational excellence progress in alignment. Syed Saleel, as Executive Director, contributes to strategic decision-making across international business development, organizational capabilities, innovation and commercial operations. His experience with Sami-Sabinsa Group and BioActives in Europe and Japan, brings valuable insight into global customer expectations, regulatory requirements and the importance of integrating scientific expertise with commercial execution.

As CEO, Vivek drives corporate strategy, global market positioning, strategic partnerships and profitable growth. Drawing on his international business experience, he focuses on building high-performing teams, strengthening customer relationships and identifying opportunities for product differentiation.

Complementing these responsibilities, Madhukumar as COO oversees manufacturing capabilities, quality systems, regulatory compliance and operational efficiency drawing from his experience with Ranbaxy, Strides and Sami-Sabinsa where he contributed to major operational projects. The company has established functional accountability across sourcing, production, engineering, quality, regulatory affairs and business development.

Through their collective leadership, the company is fostering a culture of accountability, continuous learning and cross-functional collaboration, enabling innovation and operational discipline to support sustainable expansion.

Expanding Global Reach Through Innovation and Trust

Manipal Natural's next growth phase will emphasize focused portfolio development, manufacturing modernization and stronger international partnerships. The company is prioritizing approximately 15 core botanicals while investing in capacity expansion, regulatory readiness and R&D focused on ingredient performance. Its international strategy concentrates on the United States, Europe, Japan and South Korea, supported by region-specific specifications and technical dossiers.

Manipal Natural's next growth phase will emphasize focused portfolio development, manufacturing modernization and stronger international partnerships

Syed Saleel, Executive Director

Syed Saleel is spearheading the company's US expansion initiatives, including its warehousing operations in New Jersey. This strategic presence is intended to improve product availability, shorten delivery timelines and strengthen Manipal Natural's responsiveness to customers across the American market. Potential European collaborations and established Japanese relationships offer additional opportunities.

Manufacturing priorities include strengthening compliance systems and pursuing relevant certifications, alongside resource-efficient extraction and responsible sourcing. The company also intends to deepen its research capabilities in high-bioavailability extracts, stability studies and application-specific formulations to meet increasingly sophisticated global requirements.

For Vivek Tapuriah, the objective extends beyond geographical expansion to establishing enduring commercial relationships through innovation, dependable quality and profitable growth. With the guidance of Chairman and Managing Director Sudhakar Pai and the Board, Manipal Natural is pursuing a clear ambition: to transform India's botanical strengths into globally respected ingredients. Its long-term differentiation will rest not merely on what it extracts from nature, but on the scientific assurance and consistency it delivers with every shipment.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

© 2026 India Pharma Outlook. All Rights Reserved.